Results 291 to 300 of about 56,778 (348)
Age disparities in adverse reactions of drugs used in pain therapies in Switzerland. [PDF]
Sci RepGasparovic L +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
American Journal of Clinical Dermatology, 2021
Eczematous drug eruptions are a heterogenous group of skin reactions that resemble eczema both clinically and histologically. We reviewed the literature and cataloged the systemically administered medications that cause these eruptions, along with their characteristic clinical presentations.
Amy E. Blum, Susan Burgin
openaire +2 more sources
Eczematous drug eruptions are a heterogenous group of skin reactions that resemble eczema both clinically and histologically. We reviewed the literature and cataloged the systemically administered medications that cause these eruptions, along with their characteristic clinical presentations.
Amy E. Blum, Susan Burgin
openaire +2 more sources
Clinics in Dermatology, 2022
Cutaneous adverse drug reactions are undesirable cutaneous changes caused by medications. Drug eruptions can mimic a wide range of dermatoses that include exanthematous (morbilliform), urticarial, pustular, bullous, papulosquamous, or granulomatous lesions, and sometimes these eruptions may present with annular, polycyclic, or polymorphous ...
Wei-Hsin, Wu, Chia-Yu, Chu
openaire +2 more sources
Cutaneous adverse drug reactions are undesirable cutaneous changes caused by medications. Drug eruptions can mimic a wide range of dermatoses that include exanthematous (morbilliform), urticarial, pustular, bullous, papulosquamous, or granulomatous lesions, and sometimes these eruptions may present with annular, polycyclic, or polymorphous ...
Wei-Hsin, Wu, Chia-Yu, Chu
openaire +2 more sources
Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions
Clinics in Dermatology, 2020Drug reactions are among the most common reasons for inpatient dermatology consultation. These reactions are important to identify because discontinuation of the offending agent may lead to disease remission. With the rising use of immunomodulatory and targeted therapeutics in cancer care and the increased incidence in associated reactions to these ...
Shayan, Cheraghlou, Lauren L, Levy
openaire +2 more sources